• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Japan·Consumer Cyclical·2053.T
Share

Chubu Shiryo Co., Ltd. Stocks

¥ 1955Last Updated 24.07.2026

Issuer Rating

6/7
Performance

Strong

Risk

Limited

Recommendation

Buy

Market Cap

¥ 341.16M

¥ 1955
Key Takeaways

Risk factor

Low price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Chubu Shiryo Co., Ltd., a Japanese enterprise, specializes in the development and distribution of compound animal feeds for both the agricultural and aquaculture industries. Their product line features specialized nutrition for poultry, swine, cattle, and various fish farming operations. Beyond feed, the company also markets livestock and marine products directly to retailers such as supermarkets and department stores, as well as to the hospitality sector. Chubu Shiryo further extends its activities to include the manufacturing and sale of organic composite fertilizers, the provision of sales and maintenance services for livestock equipment, and the offering of non-life insurance for livestock. Additionally, they provide essential veterinary support services, including hygiene protocols, pathological diagnostics, and expert guidance for breeding practices. Established in 1949, the company's main office is located in Nagoya, Japan.

Company Valuation

Greatly undervalued
7/7

Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITD.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

24.07.2026 23:10

Freedom recommended buying Alphabet stock after the pullback. What could hinder its growth?

24.07.2026 22:45

Key Developments in the Kazakh Market: The Stakes of the Oil War and Signals from the National Bank

24.07.2026 22:34

"The Divorce of the Century": SK CEO to Pay Ex-Wife $643 Million but Retain Control of SK Hynix

24.07.2026 21:54

A Wake-Up Call That Could Transform the AI Market: What to Look for in Hyperscalers’ Reports

24.07.2026 21:23

Brent crude fell 5%. Reuters reported on an attempt to resume negotiations between the U.S. and Iran

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026